4
Changes in Ownership
Entrada Therapeutics, Inc. Filed Acc 0001689375-24-000067
President, Research & Develop. sold 15,891 shares at an average $20.18 ($320,620)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Sethuraman Natarajan President, Research & Develop. | 2024-11-29 | Sale 10b5-1 | −100 | $20.00 | $2,000 | 160,788 | D |
| Sethuraman Natarajan President, Research & Develop. | 2024-12-02 | Sale 10b5-1 | −4,088 | $20.26 | $82,834 | 156,700 | D |
| Sethuraman Natarajan President, Research & Develop. | 2024-12-03 | Sale 10b5-1 | −11,703 | $20.15 | $235,786 | 144,997 | D |
| Open-market sales · 15,891 sh · avg $20.18 · $320,620 | |||||||
Loading xslF345X05/wk-form4_1733264681.xml…